Health News

Dementia cases in the U.S. declining: Study

A new study has found there are fewer Americans living with dementia. The study analyzed the responses from over 10,000 Americans over the age of 65 and found the dementia prevalence dropped nearly 24 percent between 2000 and 2012. Researchers aren’t completely sure what has led to the declining dementia rates, but they point out ...click here to read more

Health campaign to cut back on sugary beverages

A health campaign has been launched aiming to reduce consumption of sugary beverages. So far declines in sugary beverage sales have been seen in Maryland county. Packed with empty calories, sugary beverages have been linked to weight gain and even heart disease. The health campaign was set off in 2012 by Horizon Foundation and several ...click here to read more

Top five causes of death: CDC

The Centers for Disease Control and Prevention has revealed the list of the five leading causes of death in the U.S. Heart disease takes the spot of the number one killer, followed by cancer, stroke, lower respiratory diseases, and accidents. The CDC reported that nearly two-thirds of deaths in the U.S. are caused by one ...click here to read more

New drug shows promise in Crohn’s disease treatment

A drug known as ustekinumab (Stelara) has been found to show promise in treating Crohn’s disease in cases where other treatments have been unsuccessful. Stelara blocks inflammatory agents interleukin-12 and interleukin-23. It has been used to treat psoriasis – and most recently, approved to treat Crohn’s disease. Coauthor of the study Dr. William Sandborn explained, ...click here to read more

Twice-a-year injection may help lower cholesterol

Cholesterol-lowering remedies may soon be available in the form of a twice-a-year injection. Researchers are currently testing this injectable cholesterol-lowering drug called Inclisiran. The researchers found this drug helps lower LDL cholesterol by half or more. Based on clinical studies, the effects of the injection could last between four and six months. Before Inclisiran can ...click here to read more